0001562180-21-001243.txt : 20210218 0001562180-21-001243.hdr.sgml : 20210218 20210218081731 ACCESSION NUMBER: 0001562180-21-001243 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210216 FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZUMWALT LEANNE M CENTRAL INDEX KEY: 0001204946 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36352 FILM NUMBER: 21647720 MAIL ADDRESS: STREET 1: C/O THE ADVISORY BOARD CO WATERGATGE STREET 2: 600 NEW HAMPSHIRE AVE NW CITY: WASHINGTON STATE: DC ZIP: 20037 FORMER NAME: FORMER CONFORMED NAME: ZURNWALT LEANNE M DATE OF NAME CHANGE: 20021109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akebia Therapeutics, Inc. CENTRAL INDEX KEY: 0001517022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208756903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-2098 MAIL ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-02-16 false 0001517022 Akebia Therapeutics, Inc. AKBA 0001204946 ZUMWALT LEANNE M C/O AKEBIA THERAPEUTICS, INC. 245 FIRST ST. CAMBRIDGE MA 02142 true false false false Stock Option (Right to buy) 4.87 2021-02-16 4 A false 80200.00 0.00 A 2031-02-16 Common Stock 80200.00 80200.00 D The options will vest over three years: 33 1/3 % of the options will vest on the first anniversary of the grant date and the remaining 66 2/3 % will vest ratably on the first day of each calendar quarter thereafter. /s/ Andrea J. Paul, attorney-in-fact for LeAnne M. Zumwalt 2021-02-18